South America Continuous Renal Replacement Therapy Market

ID: MRFR/Pharma/49774-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
South America Continuous Renal Replacement Therapy Market Research Report By Product Type (Continuous Veno-Venous Hemofiltration, Continuous Veno-Venous Hemodialysis, Continuous Veno-Venous Dialysis), By End User (Hospitals, Dialysis Centers, Home Care Settings), By Techniques (Filtration, Dialysis, Both Filtration and Dialysis), By Application (Acute Kidney Injury, Chronic Kidney Disease, Multiple Organ Failure) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035
South America Continuous Renal Replacement Therapy Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.19%
2024 Market Size$ 262.4 Million
2025 Market Size$ 278.64 Million
2035 Market Size$ 508.16 Million
Key Players
Fresenius Medical Care
Baxter International
Nipro Corporation
Medtronic
Asahi Kasei Medical
Dialysis Clinic
Trends
  • Technological Advancements
  • Regulatory Support
  • Rising Awareness and Education
Opportunities
  • Growing Aging Population
  • Rising Healthcare Expenditure
  • Government Initiatives and Funding
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Acute Kidney Injury
      2. 4.1.2 Chronic Kidney Disease
      3. 4.1.3 Postoperative Care
      4. 4.1.4 Sepsis Management
    2. 4.2 Healthcare, BY Product Type (USD Million)
      1. 4.2.1 Continuous Venovenous Hemofiltration
      2. 4.2.2 Continuous Venovenous Hemodialysis
      3. 4.2.3 Continuous Arteriovenous Hemofiltration
      4. 4.2.4 Hybrid Systems
    3. 4.3 Healthcare, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Dialysis Centers
      3. 4.3.3 Home Care Settings
    4. 4.4 Healthcare, BY Technology (USD Million)
      1. 4.4.1 Conventional Systems
      2. 4.4.2 Portable Systems
      3. 4.4.3 Automated Systems
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Fresenius Medical Care (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Baxter International (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Medtronic (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Nipro Corporation (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Asahi Kasei Medical (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Dialife SA (CH)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Kawasumi Laboratories (JP)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Terumo Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 B. Braun Melsungen AG (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY END USER
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY END USER, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2026-2035 (USD Million)
      3. 7.2.3 BY END USER, 2026-2035 (USD Million)
      4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America South America Continuous Renal Replacement Therapy Market Segmentation

South America Continuous Renal Replacement Therapy Market By Application (USD Million, 2022-2035)

  • Acute Kidney Injury
  • Chronic Kidney Disease
  • Postoperative Care
  • Sepsis Management

South America Continuous Renal Replacement Therapy Market By Product Type (USD Million, 2022-2035)

  • Continuous Venovenous Hemofiltration
  • Continuous Venovenous Hemodialysis
  • Continuous Arteriovenous Hemofiltration
  • Hybrid Systems

South America Continuous Renal Replacement Therapy Market By End User (USD Million, 2022-2035)

  • Hospitals
  • Dialysis Centers
  • Home Care Settings

South America Continuous Renal Replacement Therapy Market By South America Continuous Renal Replacement Therapy Market (USD Million, 2022-2035)

  • Conventional Systems
  • Portable Systems
  • Automated Systems

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.